Infliximab-abda Intravenous and Lithium Citrate Syrup
Determining the interaction of Infliximab-abda Intravenous and Lithium Citrate Syrup and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: infliximab
Brand name: Inflectra, Remicade, Renflexis
Synonyms: Infliximab, InFLIXimab
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Infliximab-abda Intravenous-Lithium Controlled-Release and Extended-Release Tablets
- Infliximab-abda Intravenous-Lithium ER
- Infliximab-abda Intravenous-Lithium Oral Solution
- Infliximab-abda Intravenous-Lithium Salts
- Infliximab-abda Intravenous-Lithium Syrup and Oral Solution
- Infliximab-abda Intravenous-Lithobid
- Lithium Citrate Syrup-Infliximab-dyyb
- Lithium Citrate Syrup-Infliximab-dyyb Intravenous
- Lithium Citrate Syrup-Infliximab-qbtx Intravenous
- Lithium Citrate Syrup-Influenza A (H1N1) 2009 Monovalent Vaccine
- Lithium Citrate Syrup-Influenza A H1N1 Intranasal
- Lithium Citrate Syrup-Influenza A Vaccine